Thyrocare Technologies has informed that the Company has entered into Business Transfer Agreement (‘BTA’) on August 30, 2024, around 11.00 am with, Vimta Labs, by which the Company would be acquiring Vimta’s diagnostic and pathological services business as a going concern (on a slump sale basis). Completion of the said acquisition is subject to fulfilment of the Conditions Precedent (‘CP’). Details required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are given in the Disclosure Sheet attached as Annexure - 1 to this Letter.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7000.00 |
Max Healthcare Inst | 1008.35 |
Narayana Hrudayalay | 1265.30 |
Aster DM Healthcare | 442.70 |
Global Health | 1105.25 |
View more.. |